Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.globenewswire.com/news-release/2024/04/03/2856718/29517/en/MannKind-Repays-Certain-Debt-Obligations.html
https://www.globenewswire.com/news-release/2024/03/26/2852734/29517/en/MannKind-Announces-CFO-Transition.html
https://www.globenewswire.com//news-release/2024/03/11/2843565/29517/en/INHALE-3-Study-s-Initial-Meal-Challenge-Results-Comparing-Afrezza-Head-To-Head-With-Multiple-Daily-Injections-MDI-and-Insulin-Pumps.html
https://www.globenewswire.com//news-release/2024/03/05/2840233/29517/en/MannKind-Announces-New-Clinical-Data-From-Inhale-3-Study-to-be-Presented-by-Dr-Irl-B-Hirsch-at-ATTD-on-March-8.html
https://www.globenewswire.com//news-release/2024/03/04/2839910/29517/en/MannKind-Corporation-Announces-Participation-at-Upcoming-Conferences.html
https://www.globenewswire.com//news-release/2024/02/27/2836412/29517/en/MannKind-Corporation-Reports-2023-Fourth-Quarter-and-Full-Year-Financial-Results-Provides-Clinical-Development-Update.html
https://www.globenewswire.com//news-release/2024/02/20/2831617/29517/en/MannKind-Corporation-to-Hold-2023-Fourth-Quarter-and-Full-Year-Financial-Results-Conference-Call-on-February-27-2024.html
https://www.globenewswire.com//news-release/2024/02/15/2829760/29517/en/MannKind-Announces-Enrollment-Goal-Completion-of-INHALE-1-Pediatric-Diabetes-Trial-Utilizing-Afrezza.html
https://www.globenewswire.com//news-release/2024/01/02/2802534/29517/en/MannKind-and-Sagard-Healthcare-Enter-Into-Royalty-Purchase-Agreement-for-Up-to-200-Million.html
https://www.globenewswire.com//news-release/2023/12/28/2801628/29517/en/MannKind-Corporation-to-Present-at-42nd-Annual-J-P-Morgan-Healthcare-Conference.html